Search Results 1191-1200 of 19352 for hemoglobin

1. Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable); Total bilirubin < 2 x ...

2. Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 - Mayo Clinic

   Able to swallow whole capsules [Pending availability of granule formulation]. 6. Hematologic Function: Absolute neutrophil count ≥ 1200/µL, hemoglobin ≥ 9g/dL ...

3. PKCι & mTOR Inhibition With Auranofin+Sirolimus for Squamous Cell Lung Cancer - Mayo Clinic

   Hemoglobin (Hgb) ≥ 9 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or direct bilirubin ≤ ULN; Serum glutamic oxaloacetic transaminase (SGOT) ...

4. Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma - Mayo Clinic

   Hemoglobin ≥ 10.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) ≥ 10.0 g/dl is acceptable); Bilirubin ≤ 1.5 upper ...

5. Sorafenib for Hepatopulmonary Syndrome - Mayo Clinic

   Presence of cirrhosis/hepatic fibrosis and/or portal hypertension. Child-Pugh class A or B liver disease; Platelet count ≥ 30 ×10e9 per liter; Hemoglobin ≥ ...

6. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

   Hemoglobin ≥ 10 g/dL without transfusion in the 2 weeks prior to screening. Prothrombin time, international normalized ratio or activated partial ...

7. Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL; Previous diagnosis of symptomatic multiple myeloma (MM); Received single autologous stem cell transplantation 60-120 days prior to ...

8. Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis - Mayo Clinic

   Hemoglobin >7.0 gm/dL, white count >3.0 X 10(9), platelet count >100 X 10(9). Exclusion Criteria: History of HIV; Presence of active infection; New York Hear ...

9. Testing The Addition Of High Dose, Targeted Radiation To The Usual Treatment For Locally-Advanced Inoperable Non-small Cell Lung Cancer - Mayo Clinic

   - Hematologic function (e.g. platelets, leukocytes, hemoglobin) amenable, at the discretion of the treating physician, to allow for treatment with ...

10. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/deciliter; Serum Creatinine ≤ 1.5 x ULN or creatinine clearance > 40ml/min using the Cockcroft-Gault formula. Female CrCl = (140 - age ...